Danny Tobey is a trusted advisor to the
world's most prominent companies, boards,
and governments, guiding them through
transformative change and complex risk
landscapes. With deep experience in
emerging technologies, particularly
artificial intelligence, Danny provides
360-degree support throughout the
technology lifecycle, from strategic
planning and deployment to governance,
optimization, and investigations and/or
litigation defense when issues arise.
Renowned for his multidisciplinary
experience as a seasoned litigator,
medical doctor, and successful software
founder, Danny is recognized by the
Financial Times as one of the
most "consistently impactful" legal
practitioners of the past two decades and
"a pioneer in the current shift in the
practice of law from reactive to
proactive." Clients consistently praise
his "creativity, insight, and
forward-looking solutions to our most
difficult problems," with
Chambers USA and
Chambers Global describing him as
"incredibly impressive and unique" and "on
the cutting edge of practitioners." The
Library of Congress has honored his
writing as the "best of the best in the
legal profession."
As a litigator, Danny has led clients
through their most critical disputes and
investigations. He played a pivotal role
in securing one of the largest product
liability victories in pharmaceutical
history, successfully arguing key motions
in federal Daubert proceedings. Danny
achieved a unanimous reversal in a
landmark federal Research &
Development (R&D) tax case,
dramatically increasing his client's
return, and represents a leading cancer
charity in enforcing its royalty rights
for groundbreaking research. He has also
delivered precedent-setting results in
emerging technology litigation, including
the first successful resolution of a
Generative AI hallucination lawsuit for a
top global technology company and is
leading post-settlement remediation in the
first major State Attorney General
Generative AI settlement.
Danny is a sought-after counselor for
companies navigating legal risk in the
adoption and development of new
technologies, particularly Artificial
Intelligence.
Chambers Global Spotlight
recognizes him as "by far one of the top
leaders and industry experts in AI." His
thought leadership has been cited by the
United Nations for "profound insights on
AI, law, and ethics," and by Oxford for his "crucial" innovations in
red-teaming AI for legal risk. Danny has
advised at least half of the Fortune 10,
as well as most major hyperscalers and
innovators, on their most complex AI
challenges.
Leveraging his medical background, Danny
counsels leading life sciences companies
on the most advanced biotechnology issues.
Chambers USA highlights his "deep
subject matter expertise across
technology, law, and healthcare and life
sciences." He played a key legal role in
the global risk management of the first
mRNA Covid vaccine and led risk mitigation
for the first fully autonomous Food and
Drug Administration (FDA) approved
diagnostic device. Danny is a frequent
presenter on robotics and AI alongside
industry leaders such as Johnson &
Johnson.
Danny leads a hybrid legal and technical
team that harnesses AI to proactively
manage risk and prevent emerging issues.
His team has developed bespoke,
client-specific small language models for
proactive compliance, enabling early
detection of statutory risk, and has
rigorously tested AI systems for consumer
protection, product liability,
discrimination, and other legal exposures.
These innovations have earned his firm
recognition for Best Law Firm Use of AI
(American Lawyer) and Innovation
in New Services to Manage Risk (Financial Times), among other accolades.
Deeply committed to community service,
Danny has chaired the board of the
AT&T Performing Arts Center and served
on the executive committees of the Perot
Museum of Nature & Science, the
Parkland Foundation, and the Yale Law
School Association. In 2025, he was
elected to the American Law Institute.
Danny is also a co-founder of the United
Nations' AI for Good Law Track and the AI
Law & Justice Institute, reflecting
his dedication to advancing the
responsible use of technology in society.
